Expression of endothelin-1 and adrenomedullin was not altered by leptin or resistin in bovine brain microvascular endothelial cells

Hypertension Research

Volumn 29, Issue 6, 2006, Pages 443-448

  Takahashi, Kazuhiro ^a,b   Totsune, Kazuhito ^b,c   Kikuchi, Kumi ^a   Murakami, Osamu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipokine; Adrenomedullin; Endothelial; Endothelin; Obesity

Indexed keywords

ADRENOMEDULLIN; ENDOTHELIN 1; LEPTIN; MESSENGER RNA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CELL; BRAIN HYPOXIA; CATTLE; CELL CULTURE; CONTROLLED STUDY; HYPERTENSION; IMMUNOREACTIVITY; NONHUMAN; NORTHERN BLOTTING; OBESITY; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RNA ANALYSIS; VASCULAR ENDOTHELIUM;

ADRENOMEDULLIN; ANIMALS; ANOXIA; BRAIN; CATTLE; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HYPERTENSION; LEPTIN; MICROCIRCULATION; PEPTIDES; RESISTIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746292174     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.443     Document Type: Article

References (34)

1. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G: Lifetime health and economic consequences of obesity. Arch Intern Med 1999; 159: 2177-2183.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
3. Steppan CM, Bailey ST, Bhat S, et al: The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
4. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
5. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-953.
6. Li Y, Totsune K, Takeda K, Furuyama K, Shibahara S, Takahashi K: Decreased expression of adrenomedullin during adipocyte-differentiation of 3T3-L1 cells. Hypertens Res 2003; 26 (Suppl): S41-S44.
7. Li Y, Totsune K, Takeda K, Furuyama K, Shibahara S, Takahashi K: Differential expression of adrenomedullin and resistin in 3T3-L1 adipocytes treated with tumor necrosis factor-alpha. Eur J Endocrinol 2003; 149: 231-238.
8. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243-1252.
9. Quehenberger P, Exner M, Sunder-Plassmann R, et al: Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002; 90: 711-718.
10. Verma S, Li SH, Wang CH, et al: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736-740.
11. Takahashi K, Totsune K, Sone M, Kikuchi K, Murakami O: Effects of adipokines on expression of adrenomedullin and endothelin-1 in cultured vascular endothelial cells. Peptides 2005; 26: 845-851.
12. Eto T: A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001; 22: 1693-1711.
13. Takahashi K: Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century. Tohoku J Exp Med 2001; 193: 79-114.
14. Satoh F, Takahashi K, Murakami O, et al: Immunocytochemical localization of adrenomedullin-like immunore-activity in the human hypothalamus and the adrenal gland. Neurosci Lett 1996; 203: 207-210.
15. Takahashi K, Nakayama M, Totsune K, et al: Increased secretion of adrenomedullin from cultured human astrocytes by cytokines. J Neurochem 2000; 74: 99-103.
16. Takahashi K, Satoh F, Hara E, et al: Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides 1997; 18: 1117-1124.
17. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S: Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells. Biochem Biophys Res Commun 1998; 243: 514-517.
18. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S: Induction of adrenomedullin by hypoxia in cultured human coronary artery endothelial cells. Peptides 1999; 20: 769-772.
19. Sugo S, Minamino N, Shoji H, et al: Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 1994; 203: 719-726.
20. Yoshimoto T, Gochou N, Fukai N, Sugiyama T, Shichiri M, Hirata Y: Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res 2005; 28: 165-172.
21. Kanse SM, Takahashi K, Lam HC, et al: Cytokine stimulated endothelin release from endothelial cells. Life Sci 1991; 48: 1379-1384.
22. Takahashi K, Satoh F, Hara E, et al: Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells. J Neurochem 1997; 68: 726-731.
23. Takahashi K, Jones PM, Kanse SM, et al: Endothelin in the gastrointestinal tract. Presence of endothelinlike immunoreactivity, endothelin-1 messenger RNA, endothelin receptors, and pharmacological effect. Gastroenterology 1990; 99: 1660-1667.
24. Takahashi K, Totsune K, Imai Y, et al: Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin. Clin Sci (Lond) 1993; 84: 47-50.
25. Kitamura K, Kato J, Kawamoto M, et al: The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 1998; 244: 551-555.
26. Hosoda K, Masuzaki H, Ogawa Y, et al: Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 1996; 221: 234-239.
27. Fehmann HC, Heyn J: Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res 2002; 34: 671-673.
28. Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ: Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects. Diabet Med 2004; 21: 497-499.
29. Tomoda Y, Isumi Y, Katafuchi T, Minamino N: Regulation of adrenomedullin secretion from cultured cells. Peptides 2001; 22: 1783-1794.
30. Marsden PA, Brenner BM: Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 1992; 262: C854-C861.
31. Kohan DE: Production of endothelin-1 by rat mesangial cells: regulation by tumor necrosis factor. J Lab Clin Med 1992; 119: 477-484.
32. Takahashi K, Udono-Fujimori R, Totsune K, Murakami O, Shibahara S: Suppression of cytokine-induced expression of adrenomedullin and endothelin-1 by dexamethasone in T98G human glioblastoma cells. Peptides 2003; 24: 1053-1062.
33. Aubert JD, Juillerat-Jeanneret L, Leuenberger P: Expression of endothelin-1 in human broncho-epithelial and monocytic cell lines: influence of tumor necrosis factor-alpha and dexamethasone. Biochem Pharmacol 1997; 53: 547-552.
34. Barker S, Wood E, Clark AJ, Corder R: Cloning of bovine preproadrenomedullin and inhibition of its basal expression in vascular endothelial cells by staurosporine. Life Sci 1998; 62: 1407-1415.